Raloxifene Hydrochloride
Inquiry
| Post Date: | Aug 26,2015 |
| Expiry Date: | Feb 22,2016 |
| Detailed Description: |
Cas No. :82640-04-8
Quantity: 2000Kilograms Specs:USP Price:2 USD Kilograms Payment Method: T/T, Western Union, MoneyGram,bank transfer Tag:Hormone,Keoxifene,Keoxifene Hydrochloride,Evista Product Name Raloxifene Hydrochloride Synonym Raloxifene HCL,Keoxifene,Keoxifene Hydrochloride, CAS 82640-04-8 MF C28H28ClNO4S MW 510.04 Molecular Structure Assay 99% Quality Standards USP Appearance White crystalline powder Package 1kg/Foil bag Place of Origin China Brand Name SMQ Certification ISO9001, ISO14000, KOSHER Model Number 82640-04-8 MOQ 10g Ref. Price USD 1.17/g Packaging Details 1kg/bag,100grams/bag, 10grams/bag Delivery Time 1-3 days Payment Terms T/T, Western union, Money gram Supply Ability 100KGS/week 1. OverView: Evista (Raloxifene Hydrochloride) is an estrogen agonist/antagonist, referred to as a selective estrogen receptor modulator (SERM) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (Agonism) and and the blockade of estrogenic pathways in other tissues (Antagonism). 2. Why is this medication prescribed: Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods). Raloxifene is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in women who are at high risk of developing this type of cancer or who have osteoporosis. Raloxifene cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition. Raloxifene also cannot be used to decrease the risk of developing non-invasive breast cancer. Raloxifene is in a class of medications called selective estrogen receptor modulators (SERMs). Raloxifene prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density (thickness) of bone. Raloxifene decreases the risk of developing invasive breast cancer by blocking the effects of estrogen on breast tissue. This may stop the development of tumors that need estrogen to grow. |
| CAS Registry Number: | 82640-04-8 |
| Synonyms: | ;Raloxifene hydrochloride [USAN];6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride;Evista;Keoxifene hydrochloride;LY 156758;Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride;Raloxifene HCl;UNII-4F86W47BR6;[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone hydrochloride (1:1);[6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone; |
| Molecular Formula: | C28H29NO4S |
| Molecular Weight: | 475.5992 |
| Molecular Structure: | 
|
| Company: | Shenzhen SiMeiQuan Biotechnology Co., Ltd [ China ] |
| Contact: | nicole |
| Tel: | 86-755-23252301 |
| Fax: | 86-755-23252301 |
| Email: | nicole@chembj.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
